KIAA0226 (KIAA0226) (Middle Region) Peptide
KIAA0226
Reactivity: Human
Host: Synthetic
BP, WB
-
- Target See all Rubicon (KIAA0226) products
- Rubicon (KIAA0226) (KIAA0226)
- Protein Region
- Middle Region
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Sequence
- DQEGGGESQL SSVLRRSSFS EGQTLTVTSG AKKSHIRSHS DTSIASRGAP
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-KIAA0226 Antibody(ARP58950_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- Rubicon (KIAA0226) (KIAA0226)
- Background
-
KIAA0226 negatively regulates endocytic trafficking. KIAA0226 impairs the autophagosome maturation process.KIAA0226 may inhibit PIK3C3 activity.
Alias Symbols: RUBICON
Protein Interaction Partner: SMAD9,BECN1,PIK3C3,UVRAG
Protein Size: 927 - Molecular Weight
- 103 kDa
- Gene ID
- 9711
- NCBI Accession
- NM_001145642, NP_001139114
-
You are here:
